| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.091 | 0.05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.085 | 0.05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.089 | 0.06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.079 | 0.08 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.07 | 0.1 |